Ergoteles LLC Infinity Pharmaceuticals, Inc. Transaction History

Ergoteles LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$0.16 - $0.74 $100,295 - $463,866	626,846 Added 899.87%	696,506 $111,000
Q4 2022 Feb 14, 2023	SELL	$0.46 - $1.21 $155,826 - $409,892	-338,754 Reduced 82.94%	69,660 $39,000
Q3 2022 Nov 14, 2022	SELL	$0.59 - $1.7 $6,630 - $19,104	-11,238 Reduced 2.68%	408,414 $486,000
Q2 2022 Aug 12, 2022	BUY	$0.49 - $1.2 $205,629 - $503,582	419,652 New	419,652 $265,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.